Barr Susan A, Thomas Amanda, Potter Shannon, Melick Clifford F, Gavard Jeffrey A, McLennan Mary T
University of Arkansas for Medical Sciences, 4301 West Markham, Slot 518, Little Rock, AR, 72205, USA.
Louisiana State University, Baton Rouge, LA, USA.
Int Urogynecol J. 2016 Aug;27(8):1209-14. doi: 10.1007/s00192-016-2972-1. Epub 2016 Feb 19.
There is a paucity of literature on resumption of normal voiding predictors after synthetic retropubic sling insertion and lack of a standardized method of determination. Our goals were to determine the incidence of a successful voiding trial; whether clinical, operative, or urodynamic variables predict discharge with a catheter; and incidence of later retention in those who were initially successful.
We performed an internal-review-board (IRB)-approved retrospective chart review of 229 consecutive patients who underwent retropubic sling (TVT, Boston Scientific, Natick, MA, USA)) from 2001 to 2010. Exclusions were concomitant surgery or cystotomy at the time of retropubic sling insertion. All participants underwent a voiding trial in recovery consisting of 300 cc sterile-water retrograde fill and were discharged home without a catheter after single void of at least 200 cc following catheter removal.
Of 170 patients, 136 (80 %) passed the voiding trial the same day, with 165 (97 %) passing within 1 day. Factors associated with delayed voiding were age ≥65 years (p < 0.05), presence of Valsalva voiding (p < 0.01), lower body mass index (BMI) (p < 0.05), and higher gravidity (p < 0.05) and parity (p < 0.01). Age ≥65 years [adjusted odds ratio (aOR) 3.72, 95 % confidence interval (CI) 1.40-9.90, p < 0.01] and Valsalva voiding (aOR 3.89, 95 % CI 1.56-9.69, p < 0.01) remained significant independent predictors in multivariate analysis.
The majority of patients with retropubic sling can be safely discharged home the same day without a catheter after retrograde fill. Women >65 years or Valsalva voiders had nearly four times the odds of being discharged with a catheter. Most patients resume normal voiding within 24 h after retropubic sling insertion, but >65 years and Valsalva voiding are risk factors for voiding inability at discharge.
关于耻骨后合成吊带置入术后恢复正常排尿预测因素的文献较少,且缺乏标准化的判定方法。我们的目标是确定成功进行排尿试验的发生率;临床、手术或尿动力学变量是否能预测拔除导尿管后的出院情况;以及最初成功排尿者后期出现尿潴留的发生率。
我们对2001年至2010年连续229例行耻骨后吊带(TVT,美国波士顿科学公司,马萨诸塞州纳蒂克)手术的患者进行了一项经内部审查委员会(IRB)批准的回顾性病历审查。排除标准为耻骨后吊带置入时同时进行的手术或膀胱切开术。所有参与者在恢复过程中进行了一次排尿试验,包括300毫升无菌水逆行灌注,在拔除导尿管后单次排尿至少200毫升后无导尿管出院。
170例患者中,136例(80%)在同一天通过了排尿试验,165例(97%)在1天内通过。与排尿延迟相关的因素包括年龄≥65岁(p<0.05)、存在瓦尔萨尔瓦排尿(p<0.01)、较低的体重指数(BMI)(p<0.05)、较高的妊娠次数(p<0.05)和产次(p<0.01)。年龄≥65岁[调整后的优势比(aOR)3.72,95%置信区间(CI)1.40-9.90,p<0.01]和瓦尔萨尔瓦排尿(aOR 3.89,95%CI 1.56-9.69,p<0.01)在多变量分析中仍然是显著的独立预测因素。
大多数耻骨后吊带手术患者在逆行灌注后同一天可安全无导尿管出院。65岁以上或有瓦尔萨尔瓦排尿的女性出院时带导尿管的几率几乎是其他人的四倍。大多数患者在耻骨后吊带置入术后24小时内恢复正常排尿,但65岁以上和瓦尔萨尔瓦排尿是出院时排尿困难的危险因素。